These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17404536)

  • 1. [From ASCO 2006 to clinical practice].
    Pérol M
    Rev Pneumol Clin; 2006 Dec; 62(6 Pt 2):2S27-33. PubMed ID: 17404536
    [No Abstract]   [Full Text] [Related]  

  • 2. Negative data from lung cancer trial may change practice guidelines, study designs.
    McNeil C
    J Natl Cancer Inst; 2006 Nov; 98(21):1518-20. PubMed ID: 17077353
    [No Abstract]   [Full Text] [Related]  

  • 3. Refining prognosis in non-small-cell lung cancer.
    Singh T; Dhindsa J
    N Engl J Med; 2007 Jan; 356(2):190; author reply 190-1. PubMed ID: 17225287
    [No Abstract]   [Full Text] [Related]  

  • 4. [Non-small-cell lung carcinoma (NSCLC): from ASCO 2004 to clinical practice].
    Pérol M
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S46-4S52. PubMed ID: 15687995
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?
    Besse B; Le Chevalier T
    J Clin Oncol; 2008 Nov; 26(31):5014-7. PubMed ID: 18809602
    [No Abstract]   [Full Text] [Related]  

  • 6. Do we need a size-based subclassification for lung cancers larger than 3 cm?
    Pramesh CS; Mistry RC; Agarwal J
    Lung Cancer; 2005 Jul; 49(1):133-4; author reply 135. PubMed ID: 15949601
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-small cell lung cancer: adjuvant and neo-adjuvant chemotherapy.
    Brahmer JR; Ettinger DS
    Respirology; 2007 May; 12(3):320-5. PubMed ID: 17539833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early-stage NSCLC. Resectable non-small cell lung cancers: (neo) adjuvant chemotherapy].
    Berghmans T
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S72-8. PubMed ID: 18971829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a definitive answer to the question of involved-field radiotherapy for inoperable non-small-cell lung cancer?
    Lima CG; Cordova AL
    J Clin Oncol; 2008 May; 26(13):2235; author reply 2235-6. PubMed ID: 18445859
    [No Abstract]   [Full Text] [Related]  

  • 10. [Stage IV non-small cell lung cancer. What is the best treatment for relapse?].
    Sculier JP
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S78-16S83. PubMed ID: 17268341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting poor survival after resection of stage IA non-small cell lung cancer.
    Paleari L; Russo P; Cesario A; Granone P
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):241-2. PubMed ID: 18603108
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease.
    Wakelee H; Dubey S; Gandara D
    Oncologist; 2007 Mar; 12(3):331-7. PubMed ID: 17405898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer staging techniques and induction therapy: maybe timing is everything.
    Pass HI
    J Clin Oncol; 2008 Jul; 26(20):3306-7. PubMed ID: 18519951
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
    J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What treatment for a patient of PS 2-3 with stage IV non-small cell lung cancer?].
    Moro-Sibilot D; Pluquet E; Zalcman G; Bréchot JM; Souquet PJ; Debieuvre D; Morin F; Morère JF
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S120-4. PubMed ID: 18235404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is it necessary to select patients to prescribe targeted therapies in stage IV non-small-cell lung cancers?].
    Cadranel J
    Rev Pneumol Clin; 2006 Dec; 62(6 Pt 2):2S41-4. PubMed ID: 17404539
    [No Abstract]   [Full Text] [Related]  

  • 17. First-line chemotherapy for non-small-cell lung cancer: is there a superior regimen based on histology?
    Einhorn LH
    J Clin Oncol; 2008 Jul; 26(21):3485-6. PubMed ID: 18506022
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adjuvant chemotherapy for resectable non-small cell lung cancer (NSCLC)].
    Nakajima E; Katou H
    Kyobu Geka; 2008 Jan; 61(1):4-8. PubMed ID: 18186265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stage IV NSCLC. Second-line therapy for metastatic non-small cell lung cancer].
    Quoix E
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S113-8. PubMed ID: 18971835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy.
    Chen Y; Guo W; Lu Y; Zou B
    Radiother Oncol; 2008 Sep; 88(3):351-8. PubMed ID: 18722684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.